Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis Life Science Investing
Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts Life Science Investing
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer Pharmaceutical Investing
Astellas, Seagen and Merck Announce FDA Acceptance of Supplemental Biologics License Applications for PADCEV® with KEYTRUDA® for the First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer Life Science Investing
Seagen, Astellas and Merck Announce FDA Acceptance of sBLAs for PADCEV® with KEYTRUDA® for the First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer Life Science Investing
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Pharmaceutical Investing
Anti-TIGIT Domvanalimab-Containing Study Arms Improve Progression-Free Survival Compared to Anti-PD1 Alone in Phase 2 Non-Small Cell Lung Cancer Study Pharmaceutical Investing
Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain Pharmaceutical Investing
Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore Life Science Investing
U.S. FDA Approves VRAYLAR® as an Adjunctive Treatment for Major Depressive Disorder Pharmaceutical Investing
